English: ovarian carcinoma, ovarian cancer Dutch: ovariumcarcinoom, eierstokkanker
Conditions
Interventions
This study is a pragmatic, cluster randomized controlled trial. More than twenty hospitals in the Netherlands will be randomized to either 'geriatric screening care' or 'care as usual'.
In 'geriatri
Sponsors
The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NKI-AVL)
Eligibility
Inclusion criteria
Inclusion criteria: - A woman diagnosed with primary ovarian/fallopian/peritoneal carcinoma FIGO stage II, III or IV OR - A woman with a high suspicion of primary ovarian/fallopian/peritoneal carcinoma FIGO stage II, III or IV (a high suspicion of advanced stage ovarian/fallopian/peritoneal carcinoma should be based on imaging suggesting evidence of metastasized disease (i.e. signs of pelvic, abdominal or extra-abdominal metastases)) - Aged 70 years or older - Able to complete a Dutch questionnaire - Written and signed informed consent
Exclusion criteria
Exclusion criteria: - Not being able to read or write Dutch, as they are not able to complete a Dutch questionnaire
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary endpoints include the percentage of started and completed therapies (standard as well as adapted) in 'geriatric screening care' and 'care as usual' and the difference in percentage in completed treatment in both groups. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoints include health related quality of life; toxicity of treatment; progression free- and overall survival and cost-effectiveness in terms of incremental costs per quality adjusted life year from a societal perspective. | — |
Contacts
Public ContactN.J. Soolingen, van
Department of Gynaecologic Oncology, Antoni van Leeuwenhoek
Outcome results
None listed